Glaxo Forecasts 2013 Earnings Growth as 6 Drugs Await Approval

Glaxo Forecasts 2013 Earnings Growth as 6 Drugs Await Approval

Simon Dawson/Bloomberg

Glaxo is counting on the regulatory decisions to help revive the stock price after a drop last year that ran counter to a gain in the Bloomberg Europe Pharmaceutical Index of 18 companies.